Axsome Therapeutics Inc (AXSM) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $163.19
• Market Cap: $8.28B
• EPS: $-4.66
• 52-Week High: $191.50
• 52-Week Low: $86.99

Market Sentiment

Axsome Therapeutics Inc currently has a Bullish sentiment score of 0.31.

About Axsome Therapeutics Inc

Axsome Therapeutics, Inc. is a biopharmaceutical company based in New York City, dedicated to developing innovative therapies for central nervous system (CNS) disorders. The company is focused on addressing significant unmet medical needs within this therapeutic area, boasting a robust pipeline of candidates targeting conditions such as depression, migraine, and chronic pain. With a strong commitment to enhancing patient outcomes and a solid scientific foundation, Axsome is strategically posi...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Axsome Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does AXSM pay dividends?

Axsome Therapeutics Inc (AXSM) does not currently pay a regular dividend.

What is AXSM's market cap?

Axsome Therapeutics Inc (AXSM) has a market capitalization of $8.28B with a current stock price of $163.19.